Systematic review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy

被引：0
|
作者：
Antonuzzo, A. [1 ]
Bossi, P. [2 ]
Botta, L.
Bironzo, P. [3 ]
Sonetto, C. [3 ]
Musettini, G. [1 ]
Sbrana, A. [1 ]
Di Giannantonio, V. [4 ]
Locati, L. [2 ]
Di Maio, M. [3 ]
机构：
[1] Azienda Osped Univ Pisana, Polo Oncol, Pisa, Italy
[2] Fdn IRCCS, Ist Nazl Tumori, SC Oncol Med Tumori Testa Collo 3, Milan, Italy
[3] AOU San Luigi Gonzaga, UO Oncol Med, Orbassano, TO, Italy
[4] Fdn IRCCS Ist Nazl Tumori, SC Oncol Med Tumori Testa Collo 3, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw345.11
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
S11
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Systematic review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy
    Bossi, P.
    Botta, L.
    Bironzo, P.
    Sonetto, C.
    Musettini, G.
    Sbrana, A.
    Di Giannantonio, V.
    Locati, L.
    Di Maio, M.
    Antonuzzo, A.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [2] Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy
    Bossi, Paolo
    Botta, Laura
    Bironzo, Paolo
    Sonetto, Cristina
    Musettini, Gianna
    Sbrana, Andrea
    Di Giannantonio, Valerio
    Locati, Laura D.
    Di Maio, Massimo
    Antonuzzo, Andrea
    [J]. FUTURE ONCOLOGY, 2019, 15 (21) : 2543 - 2553
  • [3] Analysis of adverse events attribution and reporting in cancer clinical trials: A systematic review
    Enrico, Diego
    Waisberg, Federico
    Burton, Jeannette
    Mando, Pablo
    Chacon, Matias
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 160
  • [4] Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review
    Chowers, Michal Y.
    Gottesman, Bat Sheva
    Leibovici, Leonard
    Pielmeier, Ulrike
    Andreassen, Steen
    Paul, Mical
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (02) : 239 - 250
  • [5] The reporting of adverse events following spinal manipulation in randomized clinical trials-a systematic review
    Gorrell, Lindsay M.
    Engel, Roger M.
    Brown, Benjamin
    Lystad, Reidar P.
    [J]. SPINE JOURNAL, 2016, 16 (09): : 1143 - 1151
  • [6] The reporting of adverse events associated with spinal manipulation in randomized clinical trials: an updated systematic review
    Gorrell, Lindsay M.
    Brown, Benjamin T.
    Engel, Roger
    Lystad, Reidar P.
    [J]. BMJ OPEN, 2024, 14 (01):
  • [7] Adverse events reporting in phase III oncology clinical trials of checkpoint inhibitors: A systematic review
    Joulia, M-L.
    Barhli, A.
    Tournigand, C.
    Kempf, E.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S725 - S725
  • [8] Quality of adverse events reporting in clinical trials of COVID-19 drugs: A systematic review
    Madi, Karima
    Flumian, Clara
    Olivier, Pascale
    Sommet, Agnes
    Montastruc, Francois
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 219 - 219
  • [9] Quality of adverse events reporting in clinical trials of COVID-19 drugs: A systematic review
    Madi, K.
    Flumian, C.
    Olivier, P.
    Sommet, A.
    Montastruc, F.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 52 - 53
  • [10] Adverse events reporting in phase 3 oncology clinical trials of checkpoint inhibitors: A systematic review
    Barhli, Aline
    Joulia, Marie-Liesse
    Tournigand, Christophe
    Kempf, Emmanuelle
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 157
12345